Fed Regist. 2014 May 27;79(101):30239-353.
This final rule addresses various requirements applicable to health insurance issuers, Affordable Insurance Exchanges (``Exchanges''), Navigators, non-Navigator assistance personnel, and other entities under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively referred to as the Affordable Care Act). Specifically, the rule establishes standards related to product discontinuation and renewal, quality reporting, non-discrimination standards, minimum certification standards and responsibilities of qualified health plan (QHP) issuers, the Small Business Health Options Program, and enforcement remedies in Federally-facilitated Exchanges. It also finalizes: A modification of HHS's allocation of reinsurance collections if those collections do not meet our projections; certain changes to allowable administrative expenses in the risk corridors calculation; modifications to the way we calculate the annual limit on cost sharing so that we round this parameter down to the nearest $50 increment; an approach to index the required contribution used to determine eligibility for an exemption from the shared responsibility payment under section 5000A of the Internal Revenue Code; grounds for imposing civil money penalties on persons who provide false or fraudulent information to the Exchange and on persons who improperly use or disclose information; updated standards for the consumer assistance programs; standards related to the opt-out provisions for self-funded, non-Federal governmental plans and related to the individual market provisions under the Health Insurance Portability and Accountability Act of 1996 including excepted benefits; standards regarding how enrollees may request access to non-formulary drugs under exigent circumstances; amendments to Exchange appeals standards and coverage enrollment and termination standards; and time-limited adjustments to the standards relating to the medical loss ratio (MLR) program. The majority of the provisions in this rule are being finalized as proposed.
本最终规则涉及适用于健康保险发行人、平价保险交易所(“交易所”)、导航员、非导航员协助人员以及《患者保护与平价医疗法案》和《2010年医疗保健与教育协调法案》(统称为《平价医疗法案》)下的其他实体的各种要求。具体而言,该规则确立了与产品停售和续保、质量报告、非歧视标准、合格健康计划(QHP)发行人的最低认证标准和责任、小企业健康选择计划以及联邦政府设立的交易所中的执法补救措施相关的标准。它还最终确定了:如果再保险保费收入未达到我们的预期,对卫生与公众服务部(HHS)再保险保费收入分配的调整;风险走廊计算中允许的行政费用的某些变更;我们计算年度费用分摊限额的方式的变更,以便将此参数向下舍入到最接近的50美元增量;一种对用于确定根据《国内税收法典》第5000A条豁免分担责任付款资格的所需缴款进行指数化的方法;对向交易所提供虚假或欺诈性信息的人员以及不当使用或披露信息的人员处以民事罚款的依据;消费者援助计划的更新标准;与自筹资金的非联邦政府计划的退出条款以及与1996年《健康保险流通与责任法案》(包括除外福利)下的个人市场条款相关的标准;关于参保人在紧急情况下如何请求获取非处方药的标准;对交易所上诉标准以及承保登记和终止标准的修订;以及对与医疗损失率(MLR)计划相关的标准的限时调整。本规则中的大多数条款按提议最终确定。